Impact of covid-19 on remote cardiovascular endpoints in patients with sick sinus syndrome and implanted pacemaker

The impact of COVID-19 incidence on long-term cardiovascular endpoints in patients with sick sinus syndrome (SSS) and with an implanted pacemaker has been studied. Patients with COVID-19 and no COVID-19 were examined. The follow-up period was 30 months and the endpoints were cardiovascular death, myocardial infarction, stroke and cardiovascular hospitalization.comparison of the incidence of adverse cardiovascular endpoints in the COVID-19 and control groups showed no differences in all endpoints according to the chi-square test, with the exception of frequency of myocardial infarction in the “COVID-19”. The close relationship between tachybradicardia, microvascular dysfunction and coronary artery disease, and at the same time the impossibility of modulating the heart rhythm in the presence of vvegetative vascular dystonia and an established pacemaker assumed that autonomic dysfunction in postcoid patients caused myocardial ischemia and, as a result, an increase of myocardial infarction. Conclusion. During long-term follow-up, COVID-19 in patients with SSS increased the risk of myocardial infarction.

1. Cardiovascular events follow-up analysis in patients with sinus node dysfunction and implanted pacemaker / E.A. Badykova [et al.] // Russian Journal of Cardiology. 2019;(2):53-57. doi: 10.15829/1560-4071-2019-2-53-57.

2. Bradyarrhythmia and conductance disorders. Clinical recommendations 2020 / A.S. Revishvili [et al. ] // Russian Cardiac Journal. 2021;(4):203-245. doi: 10.15829/1560-4071--2021-4448.

3. Bradyarrhythmias in patients with COVID-19: marker of poor prognosis? / JS Chinitz [et al.] // Pacing Clin Electrophysiol. 2020;43:1199–1204. doi:10.1111/pace.14042.

4. Cardiac complications in patients with COVID-19: A systematic review / E Brogi [et al.] // тJ Anesth Analg Cri. Care. 2022;2:18. doi:10.1186/s44158-022-00046-7

5. Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden / А. Fedorowski [et al.] // Nat Rev Cardiol. 2024 Jun;21(6):379-395. doi: 10.1038/s41569-023-00962-3.

6. Characteristics of bradyarrhythmia in patients with COVID-19: Systematic scoping review / T Nagamine [et al.] // Pacing Clin Electrophysiol. 2022;45(4):556-566. doi: 10.1111/pace.14466.

7. Characterization of Cardiac Autonomic Function in COVID-19 Using Heart Rate Variability: A Hospital Based Preliminary Observational Study / D Kaliyaperumal [et al.] // J Basic Clin Physiol Pharmacol. 2021;32:247–253. doi: 10.1515/jbcpp-2020-0378.

8. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies / R Gopinathannair [et al.] // J Interv Card Electrophysiol. 2020; 59: 329-336. doi: 10.1007/s10840-020-00789-9.

9. Heart Rate Variability and Cardiac Autonomic Functions in Post-COVID / LD Asarcikli, [et al.] // Period J Interv Card Electrophysiol. 2022;63:715-721. doi: 10.1007/s10840-022-01138-8.

10. Long-term cardiovascular outcomes of COVID-19 / Y Xie [et al.] // Nat Med. 2022;28(3):583-590. doi: 10.1038/s41591-022-01689-3.

11. Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series / G Peigh [et al.] // Eur Heart J Case Rep. 2020 May 8;4(FI1):1-6. doi: 10.1093/ehjcr/ytaa132.

12. Reversible sinus node dysfunction in novel COVID-19 infection: two years of follow-up / Ch. Sundaram [et al.] // IHJ Cardiovascular Case Reports (CVCR). 2023;7(3-4):89-91. doi:10.1016/j.ihjccr.2023.11.001.

13. The variety of cardiovascular presentations of COVID-19 / JA Fried [et. al.] // Circulation. 2020;141(23):1930–1936. doi: 10.1161/CIRCU-LATIONAHA.120.047164.